Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis
- PMID: 21812858
- DOI: 10.1111/j.1349-7006.2011.02052.x
Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis
Abstract
Tumor metastasis is a complex multistep process by which cells from the primary tumor invade tissues, move through the vasculature, settle at distant sites and eventually grow to form secondary tumors. Altered tyrosine phosphorylation signals in cancer cells contribute to a number of aberrant characteristics involved in tumor invasion and metastasis. CUB domain-containing protein 1 (CDCP1) is a substrate of Src family kinases and has been shown to regulate anoikis resistance, migration and matrix degradation during tumor invasion and metastasis in a tyrosine phosphorylation-dependent manner. Knockdown of CDCP1 blocks tumor metastasis or peritoneal dissemination in vivo, without significantly affecting cell proliferation. Moreover, expression levels of CDCP1 are of prognostic value in several cancers. Here, we summarize the studies on CDCP1, focusing on structure and signal transduction, to gain insight into its role in cancer progression. Understanding the signaling pathways regulated by CDCP1 could help establish novel therapeutic strategies against the progression of cancer.
© 2011 Japanese Cancer Association.
Similar articles
-
CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.Cancer Res. 2010 Jun 15;70(12):5136-46. doi: 10.1158/0008-5472.CAN-10-0220. Epub 2010 May 25. Cancer Res. 2010. PMID: 20501830
-
CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.Mol Cell Biol. 2007 Nov;27(21):7649-60. doi: 10.1128/MCB.01246-07. Epub 2007 Sep 4. Mol Cell Biol. 2007. PMID: 17785447 Free PMC article.
-
Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration.Biochem Biophys Res Commun. 2011 Oct 14;414(1):226-32. doi: 10.1016/j.bbrc.2011.09.062. Epub 2011 Sep 17. Biochem Biophys Res Commun. 2011. PMID: 21945930
-
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.Cancer Res. 1996 Dec 1;56(23):5309-18. Cancer Res. 1996. PMID: 8968075 Review.
-
Src signaling in cancer invasion.J Cell Physiol. 2010 Apr;223(1):14-26. doi: 10.1002/jcp.22011. J Cell Physiol. 2010. PMID: 20049846 Review.
Cited by
-
Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer.J Oncol. 2022 Aug 31;2022:1469354. doi: 10.1155/2022/1469354. eCollection 2022. J Oncol. 2022. PMID: 36090897 Free PMC article.
-
Inflammo-immune perspective on the association of eight migraine risk factors with migraine: a multi-omics Mendelian randomization study.Front Neurol. 2024 Aug 7;15:1440995. doi: 10.3389/fneur.2024.1440995. eCollection 2024. Front Neurol. 2024. PMID: 39170074 Free PMC article.
-
Heat shock protein 20 suppresses breast carcinogenesis by inhibiting the MAPK and AKT signaling pathways.Oncol Lett. 2022 Nov 3;24(6):462. doi: 10.3892/ol.2022.13582. eCollection 2022 Dec. Oncol Lett. 2022. PMID: 36380873 Free PMC article.
-
Activation of Cytotoxic Lymphocytes Through CD6 Enhances Killing of Cancer Cells.Res Sq [Preprint]. 2023 Oct 9:rs.3.rs-3405677. doi: 10.21203/rs.3.rs-3405677/v1. Res Sq. 2023. Update in: Cancer Immunol Immunother. 2024 Jan 27;73(2):34. doi: 10.1007/s00262-023-03578-1. PMID: 37886483 Free PMC article. Updated. Preprint.
-
Targeting CDCP1 dimerization in triple-negative breast cancer.Cell Cycle. 2016 Sep 16;15(18):2385-6. doi: 10.1080/15384101.2016.1204849. Epub 2016 Jun 30. Cell Cycle. 2016. PMID: 27362899 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous